ID

21236

Description

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00313248

Link

https://clinicaltrials.gov/show/NCT00313248

Keywords

Versions (1)
  1. 4/16/17 4/16/17 -
Uploaded on

April 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Neoplasm NCT00313248

English

Eligibility Breast Neoplasm NCT00313248

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic breast cancer (meaning the cancer has spread beyond its original location)
Description

metastatic breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C0278488
at least one measurable lesion by ct or mri
Description

breast cancer measurable lesion

Data type

boolean

Alias
UMLS CUI [1,1]
C0006142
UMLS CUI [1,2]
C1513041
UMLS CUI [1,3]
C0011923
progression of disease following previous therapy for breast cancer
Description

progression after breast cancer therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0006142
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0242656
have received previous treatment with anthracyclines (e.g. doxorubicin[adriamycin or doxil] or epirubicin [ellence]), taxanes (paclitaxel [taxol or abraxane] or docetaxel [taxotere]) for your breast cancer
Description

anthracyclines or taxanes therapy

Data type

boolean

Alias
UMLS CUI [1]
C0282564
UMLS CUI [2]
C0796419
not be pregnant
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
additional criteria to be determined at screening visit.
Description

additional inclusion criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1524062
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 3 previous chemotherapy regimens
Description

previous chemotherapy regimens

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
more than one treatment with non cytotoxic agents for breast cancer therapy (e.g. herceptin [trastuzumab] or avastin [bevacizumab)
Description

breast cancer therapy with non cytotoxic agents

Data type

boolean

Alias
UMLS CUI [1,1]
C0006142
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2827065
prior treatment with epothilones (e.g. ixabepilone)
Description

treatment with epothilones

Data type

boolean

Alias
UMLS CUI [1]
C1136012
symptomatic brain metastases
Description

symptomatic brain metastases

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
additional criteria to be determined at screening visit
Description

additional exclusion criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062
Back to the top of the page

Similar models

Eligibility Breast Neoplasm NCT00313248

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
metastatic breast cancer
Item
metastatic breast cancer (meaning the cancer has spread beyond its original location)
boolean
C0278488 (UMLS CUI [1])
breast cancer measurable lesion
Item
at least one measurable lesion by ct or mri
boolean
C0006142 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
progression after breast cancer therapy
Item
progression of disease following previous therapy for breast cancer
boolean
C0006142 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,3])
anthracyclines or taxanes therapy
Item
have received previous treatment with anthracyclines (e.g. doxorubicin[adriamycin or doxil] or epirubicin [ellence]), taxanes (paclitaxel [taxol or abraxane] or docetaxel [taxotere]) for your breast cancer
boolean
C0282564 (UMLS CUI [1])
C0796419 (UMLS CUI [2])
pregnancy
Item
not be pregnant
boolean
C0032961 (UMLS CUI [1])
additional inclusion criteria
Item
additional criteria to be determined at screening visit.
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy regimens
Item
more than 3 previous chemotherapy regimens
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
breast cancer therapy with non cytotoxic agents
Item
more than one treatment with non cytotoxic agents for breast cancer therapy (e.g. herceptin [trastuzumab] or avastin [bevacizumab)
boolean
C0006142 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2827065 (UMLS CUI [1,3])
treatment with epothilones
Item
prior treatment with epothilones (e.g. ixabepilone)
boolean
C1136012 (UMLS CUI [1])
symptomatic brain metastases
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
additional exclusion criteria
Item
additional criteria to be determined at screening visit
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial